| scholarly article | Q13442814 |
| P50 | author | Anne Imberty | Q16527091 |
| Rabia Sadir | Q125250918 | ||
| P2093 | author name string | Hugues Lortat-Jacob | |
| Françoise Baleux | |||
| P433 | issue | 42 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | proteolysis | Q33123 |
| oligosaccharide | Q320607 | ||
| P304 | page(s) | 43854-43860 | |
| P577 | publication date | 2004-08-02 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. | |
| P478 | volume | 279 |
| Q34092009 | A Comprehensive Analysis of CXCL12 Isoforms in Breast Cancer(1,2.) |
| Q27681101 | A Model of GAG/MIP-2/CXCR2 Interfaces and Its Functional Effects |
| Q37925469 | A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients |
| Q39687869 | Abnormally High Content of Free Glucosamine Residues Identified in a Preparation of Commercially Available Porcine Intestinal Heparan Sulfate |
| Q37353939 | Altered SDF-1/CXCR4 axis in patients with primary myelofibrosis and in the Gata1 low mouse model of the disease |
| Q34755199 | An angiotensin-converting enzyme inhibitor modulates stromal-derived factor-1 through CD26/dipeptidyl peptidase IV to inhibit laser-induced choroidal neovascularization |
| Q41634261 | Binding of the chemokine CXCL12α to its natural extracellular matrix ligand heparan sulfate enables myoblast adhesion and facilitates cell motility |
| Q38690194 | CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology |
| Q92092019 | CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells |
| Q54346253 | CXCL12γ isoform is expressed on endothelial and dendritic cells in rheumatoid arthritis synovium and regulates T cell activation. |
| Q36291260 | CXCR4 chemokine receptors, histone deacetylase inhibitors and acute lymphoblastic leukemia |
| Q36347213 | CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model. |
| Q36918688 | Chemokines: novel targets for breast cancer metastasis |
| Q36488894 | Clinical utilization of chemokines to combat cancer: the double-edged sword |
| Q38274775 | Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands |
| Q36011762 | Cytokines and growth factors cross-link heparan sulfate |
| Q38194193 | Demystifying heparan sulfate-protein interactions. |
| Q39103371 | Diabetes, hypertension, and chronic kidney disease progression: role of DPP4. |
| Q60935311 | Differential Effects of Posttranslational Modifications of CXCL8/Interleukin-8 on CXCR1 and CXCR2 Internalization and Signaling Properties |
| Q39900071 | Differential effects of serine proteases on the migration of normal and tumor cells: implications for tumor microenvironment |
| Q35272247 | Distinct roles of CSF-1 isoforms in lupus nephritis |
| Q41855206 | Effect of zinc and nitric oxide on monocyte adhesion to endothelial cells under shear stress |
| Q37227984 | Electron detachment dissociation of dermatan sulfate oligosaccharides |
| Q41855907 | Electron-induced dissociation of glycosaminoglycan tetrasaccharides |
| Q24310633 | Endolyn (CD164) modulates the CXCL12-mediated migration of umbilical cord blood CD133+ cells |
| Q42057790 | Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1/CXCR4 axis |
| Q33831103 | Entry kinetics and cell-cell transmission of surface-bound retroviral vector particles |
| Q53563511 | Eotaxin selectively binds heparin. An interaction that protects eotaxin from proteolysis and potentiates chemotactic activity in vivo. |
| Q87447988 | Exploring the glycosaminoglycan-protein interaction network by glycan-mediated pull-down proteomics |
| Q28575532 | Expression of syndecan-2 in the amoeboid microglial cells and its involvement in inflammation in the hypoxic developing brain |
| Q30568524 | Fell-Muir Lecture: Heparan sulphate and the art of cell regulation: a polymer chain conducts the protein orchestra |
| Q42366882 | Glycosaminoglycan Interactions with Chemokines Add Complexity to a Complex System |
| Q43283594 | Glycosaminoglycan mimetics inhibit SDF-1/CXCL12-mediated migration and invasion of human hepatoma cells. |
| Q38841772 | Glycosaminoglycan silencing by engineered CXCL12 variants |
| Q47327922 | Glycosaminoglycan-Mediated Downstream Signaling of CXCL8 Binding to Endothelial Cells |
| Q38681182 | Glycosaminoglycans Regulate CXCR3 Ligands at Distinct Levels: Protection against Processing by Dipeptidyl Peptidase IV/CD26 and Interference with Receptor Signaling. |
| Q92132671 | HS and Inflammation: A Potential Playground for the Sulfs? |
| Q58585910 | Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity |
| Q35059448 | Heparan sulfate proteoglycans |
| Q36508793 | Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus |
| Q27004059 | Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibition |
| Q35691528 | Identification of novel dipeptidyl peptidase 9 substrates by two-dimensional differential in-gel electrophoresis |
| Q42676530 | In vitro and in vivo evaluation of cord blood hematopoietic stem and progenitor cells amplified with glycosaminoglycan mimetic |
| Q39128225 | Incorporation of heparin-binding proteins into preformed dextran sulfate-chitosan nanoparticles |
| Q24641851 | Influence of charge state and sodium cationization on the electron detachment dissociation and infrared multiphoton dissociation of glycosaminoglycan oligosaccharides |
| Q45889148 | Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors |
| Q34004904 | Interference with glycosaminoglycan-chemokine interactions with a probe to alter leukocyte recruitment and inflammation in vivo. |
| Q37261120 | LECT2 drives haematopoietic stem cell expansion and mobilization via regulating the macrophages and osteolineage cells. |
| Q57144790 | Localized SDF-1α Delivery Increases Pro-Healing Bone Marrow-Derived Cells in the Supraspinatus Muscle Following Severe Rotator Cuff Injury |
| Q47365249 | Matrix metalloproteinase and heparin-stimulated serine proteinase activities in post-prostate massage urine of men with prostate cancer |
| Q37132063 | Molecular basis of glycosaminoglycan heparin binding to the chemokine CXCL1 dimer |
| Q51568879 | Molecular modeling of the interaction between heparan sulfate and cellular growth factors: bringing pieces together. |
| Q37641792 | Natural nitration of CXCL12 reduces its signaling capacity and chemotactic activity in vitro and abrogates intra-articular lymphocyte recruitment in vivo. |
| Q46630381 | Neuropeptide Y regulates a vascular gateway for hematopoietic stem and progenitor cells |
| Q37684330 | Neutralizing endogenous chemokines with small molecules. Principles and potential therapeutic applications. |
| Q51735732 | Novel Anti-Inflammatory Peptides Based on Chemokine-Glycosaminoglycan Interactions Reduce Leukocyte Migration and Disease Severity in a Model of Rheumatoid Arthritis. |
| Q37728450 | Oligomannurarate sulfate inhibits CXCL12/SDF-1-mediated proliferation and invasion of human tumor cells in vitro |
| Q49524220 | Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands. |
| Q57584127 | Peroxynitrite Exposure of CXCL12 Impairs Monocyte, Lymphocyte and Endothelial Cell Chemotaxis, Lymphocyte Extravasation and Anti-HIV-1 Activity |
| Q93017651 | Post-Translational Modification-Dependent Activity of Matrix Metalloproteinases |
| Q43181552 | Preparation and characterization of SDF-1α-chitosan-dextran sulfate nanoparticles |
| Q38303432 | Profiling sulfation/epimerization pattern of full-length heparan sulfate by NMR following cell culture 13C-glucose metabolic labeling |
| Q47719302 | Proteoglycans as Immunomodulators of the Innate Immune Response to Lung Infection |
| Q37760881 | Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection |
| Q38595801 | Proteolytic processing of SDF-1α by matrix metalloproteinase-2 impairs CXCR4 signaling and reduces neural progenitor cell migration |
| Q28072580 | Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26 |
| Q48166200 | SDF-1 liposomes promote sustained cell proliferation in mouse diabetic wounds |
| Q42878149 | SDF-1α in glycan nanoparticles exhibits full activity and reduces pulmonary hypertension in rats |
| Q27643703 | Structural and Functional Basis of CXCL12 (Stromal Cell-derived Factor-1 ) Binding to Heparin |
| Q38022773 | Structure-based design of decoy chemokines as a way to explore the pharmacological potential of glycosaminoglycans. |
| Q38666664 | Sulfated glycopeptide nanostructures for multipotent protein activation |
| Q34943513 | Surface-templated hydrogel patterns prompt matrix-dependent migration of breast cancer cells towards chemokine-secreting cells |
| Q35918992 | Syndecan-4 shedding is involved in the oxidative stress and inflammatory responses in left atrial tissue with valvular atrial fibrillation |
| Q34353023 | Synergistic effects of SDF-1α chemokine and hyaluronic acid release from degradable hydrogels on directing bone marrow derived cell homing to the myocardium |
| Q91973506 | Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation |
| Q38290246 | The "in and out" of glucosamine 6-O-sulfation: the 6th sense of heparan sulfate. |
| Q33354115 | The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins |
| Q33851544 | The Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering Applications |
| Q36065054 | The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice. |
| Q36298889 | The agouti-related peptide binds heparan sulfate through segments critical for its orexigenic effects |
| Q36369400 | The effect of stromal cell-derived factor-1α/heparin coating of biodegradable vascular grafts on the recruitment of both endothelial and smooth muscle progenitor cells for accelerated regeneration |
| Q37021772 | The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells |
| Q33304448 | The novel CXCL12gamma isoform encodes an unstructured cationic domain which regulates bioactivity and interaction with both glycosaminoglycans and CXCR4. |
| Q36569379 | The role of heparan sulphate in inflammation |
| Q51590709 | The structural investigation of glycosaminoglycan binding to CXCL12 displays distinct interaction sites. |
| Q38678399 | The sweet spot: how GAGs help chemokines guide migrating cells |
| Q62019365 | The unique structural and functional features of CXCL12 |
| Q38218886 | Transplantation and inflammation: implications for the modification of chemokine function |
Search more.